Sequencing Technology

The gene fusion assay maker is the sixth member to join the consortium, which also includes Illumina and several pharmaceutical companies.

The Center for Human Genetics and Laboratory Medicine's Prenatalis test is based on Illumina's Verifi technology. 

Qiagen believes it has gained access to a relatively simple and inexpensive technology to bolster its offerings in the growing single-cell molecular biology market.

Birmingham Women's NHS Foundation Trust said it is partnering with Illumina to develop an NIPT, which it hopes to start offering in September.

Using a combination of approaches, researchers characterized influenza A viruses at two live animal swine markets in Minnesota.

Direct sensing bioFETs and methods of manufacture
Pen-shaped device for biological sample preparation and analysis
Devices and methods for biological sample preparation
Methods for treating infection involving identification of a carbapanemase gene
Artificial DNA sequence with optimized leader function in 5' (5'-UTR) for the improved expression of heterologous proteins in plants
Methods and compositions for amplification of nucleic acids

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."

Sep
17
Sponsored by
Omicia

This online seminar will provide examples of how commercial and hospital-affiliated clinical labs are successfully developing and deploying high-throughput next-generation sequencing-based testing services for genetic diseases. 

Oct
15
Sponsored by
Parabase

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit.